It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2017.
2017 | Chennai, Tamil Nadu, India | Converted to LLPNeocardio Diagnostics Private Limited, a converted to llp private limited company, was established on 26 October 2017 in Chennai, Tamil Nadu, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U15100TN2017PTC119254. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
Formerly known as Ki&A Associates Private Limited. It upholds a compliant status. Past directors included Karthik Anand Reddy, Fragkiskos Samaras, Dimitrios Dellis. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 3Rd Floor, Jhaver Plaza 1-A, Nungambakkam High Road, Chennai, Tamil Nadu, 600034.
U15100TN2017PTC119254
119254
26 October 2017
₹2.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Converted to LLP
Explore comprehensive insights into Neocardio Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 May 2020 | Past |
| Pramod Abcsdd | Director | 21 May 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 01 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neocardio Diagnostics Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 92.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Neocardio Diagnostics had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Neocardio Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neocardio Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neocardio Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neocardio Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
The activity Neocardio Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was completed.
Neocardio Diagnostics Private Limited was registered on 26 Oct 2017 with Roc Chennai & aged 8 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Neocardio Diagnostics Private Limited is U15100TN2017PTC119254.
Neocardio Diagnostics Private Limited is headquartered at 3Rd Floor, Jhaver Plaza 1-A, Nungambakkam High Road, Chennai, Tamil Nadu, 600034.
Neocardio Diagnostics Private Limited was incorporated on 26 October 2017.
The primary industry of Neocardio Diagnostics Private Limited is Healthcare.
Neocardio Diagnostics Private Limited is unlisted.
The authorized capital of Neocardio Diagnostics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Neocardio Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX